Treatment of Advanced Renal Cell Carcinoma With Quinacrine

NCT00574483 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped reevaluation of compound development

Conditions

Renal Cell Carcinoma

Interventions

DRUG: quinacrine

Sponsor

Cleveland BioLabs